AU7490098A - Cationic amphiphile formulations - Google Patents
Cationic amphiphile formulationsInfo
- Publication number
- AU7490098A AU7490098A AU74900/98A AU7490098A AU7490098A AU 7490098 A AU7490098 A AU 7490098A AU 74900/98 A AU74900/98 A AU 74900/98A AU 7490098 A AU7490098 A AU 7490098A AU 7490098 A AU7490098 A AU 7490098A
- Authority
- AU
- Australia
- Prior art keywords
- cationic amphiphile
- formulations
- amphiphile formulations
- cationic
- amphiphile
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4659997P | 1997-05-15 | 1997-05-15 | |
| US60046599 | 1997-05-15 | ||
| PCT/US1998/009974 WO1998051285A2 (en) | 1997-05-15 | 1998-05-15 | Cationic amphiphile formulations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU7490098A true AU7490098A (en) | 1998-12-08 |
Family
ID=21944334
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU74900/98A Abandoned AU7490098A (en) | 1997-05-15 | 1998-05-15 | Cationic amphiphile formulations |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU7490098A (en) |
| WO (1) | WO1998051285A2 (en) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU768542C (en) | 1998-04-08 | 2004-06-17 | Celltech R & D Limited | Lipids |
| US6852334B1 (en) | 1999-04-20 | 2005-02-08 | The University Of British Columbia | Cationic peg-lipids and methods of use |
| WO2000062813A2 (en) * | 1999-04-20 | 2000-10-26 | The University Of British Columbia | Cationic peg-lipids and methods of use |
| AUPQ259399A0 (en) * | 1999-09-01 | 1999-09-23 | Lustre Investments Pte Ltd | Therapeutic agents |
| US7608598B2 (en) | 2000-01-10 | 2009-10-27 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Use of lipid conjugates in the treatment of conjunctivitis |
| US8076312B2 (en) | 2000-01-10 | 2011-12-13 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd | Use of lipid conjugates in the treatment of disease |
| US9040078B2 (en) | 2000-01-10 | 2015-05-26 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Use of lipid conjugates in the treatment of diseases of the nervous system |
| US7141552B2 (en) * | 2000-01-10 | 2006-11-28 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Use of lipid conjugates in the treatment of diseases |
| US8501701B2 (en) | 2000-01-10 | 2013-08-06 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Use of lipid conjugates in the treatment of disease |
| US7811999B2 (en) | 2000-01-10 | 2010-10-12 | Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. | Use of lipid conjugates in the treatment of diseases |
| US7772196B2 (en) | 2000-01-10 | 2010-08-10 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Use of lipid conjugates in the treatment of diseases |
| US7893226B2 (en) | 2004-09-29 | 2011-02-22 | Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. | Use of lipid conjugates in the treatment of diseases |
| US8916539B2 (en) | 2000-01-10 | 2014-12-23 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Use of lipid conjugates in the treatment of disease |
| US8304395B2 (en) | 2000-01-10 | 2012-11-06 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Lipid conjugates in the treatment of disease |
| US7189705B2 (en) | 2000-04-20 | 2007-03-13 | The University Of British Columbia | Methods of enhancing SPLP-mediated transfection using endosomal membrane destabilizers |
| AU5454801A (en) * | 2000-04-20 | 2001-11-07 | Univ British Columbia | Methods of enhancing splp-mediated transfection using endosomal membrane destabilizers |
| US8883761B2 (en) | 2001-01-10 | 2014-11-11 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Use of lipid conjugates in the treatment of diseases associated with vasculature |
| ATE485031T1 (en) | 2002-06-28 | 2010-11-15 | Protiva Biotherapeutics Inc | METHOD AND DEVICE FOR PRODUCING LIPOSOMES |
| EP2567693B1 (en) | 2003-07-16 | 2015-10-21 | Protiva Biotherapeutics Inc. | Lipid encapsulated interfering RNA |
| NZ592917A (en) | 2003-09-15 | 2012-12-21 | Protiva Biotherapeutics Inc | Stable polyethyleneglycol (PEG) dialkyloxypropyl (DAA) lipid conjugates |
| MXPA06012722A (en) | 2004-05-05 | 2007-02-14 | Atugen Ag | Lipids, lipid complexes and use thereof. |
| US7799565B2 (en) | 2004-06-07 | 2010-09-21 | Protiva Biotherapeutics, Inc. | Lipid encapsulated interfering RNA |
| KR101366482B1 (en) | 2004-12-27 | 2014-02-21 | 사일런스 테라퓨틱스 아게 | Coated lipid complexes and their use |
| US8906882B2 (en) | 2005-11-17 | 2014-12-09 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Lipid conjugates in the treatment of allergic rhinitis |
| US8859524B2 (en) | 2005-11-17 | 2014-10-14 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Lipid conjugates in the treatment of chronic rhinosinusitis |
| WO2008009477A2 (en) | 2006-07-21 | 2008-01-24 | Silence Therapeutics Ag | Means for inhibiting the expression of protein kinase 3 |
| CA2705785A1 (en) | 2006-11-14 | 2008-05-22 | Saul Yedgar | Use of lipid conjugates in the treatment of diseases or disorders of the eye |
| WO2009127060A1 (en) | 2008-04-15 | 2009-10-22 | Protiva Biotherapeutics, Inc. | Novel lipid formulations for nucleic acid delivery |
| AU2010247814B2 (en) | 2009-05-11 | 2015-08-13 | Celsus Therapeutics Plc | Lipid-polymer conjugates, their preparation and uses thereof |
| US8569256B2 (en) | 2009-07-01 | 2013-10-29 | Protiva Biotherapeutics, Inc. | Cationic lipids and methods for the delivery of therapeutic agents |
| US9018187B2 (en) | 2009-07-01 | 2015-04-28 | Protiva Biotherapeutics, Inc. | Cationic lipids and methods for the delivery of therapeutic agents |
| CA2767127A1 (en) | 2009-07-01 | 2011-01-06 | Protiva Biotherapeutics, Inc. | Novel lipid formulations for delivery of therapeutic agents to solid tumors |
| WO2012000104A1 (en) | 2010-06-30 | 2012-01-05 | Protiva Biotherapeutics, Inc. | Non-liposomal systems for nucleic acid delivery |
| AU2021385572A1 (en) | 2020-11-25 | 2023-06-22 | Akagera Medicines, Inc. | Lipid nanoparticles for delivery of nucleic acids, and related methods of use |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6071890A (en) * | 1994-12-09 | 2000-06-06 | Genzyme Corporation | Organ-specific targeting of cationic amphiphile/DNA complexes for gene therapy |
-
1998
- 1998-05-15 AU AU74900/98A patent/AU7490098A/en not_active Abandoned
- 1998-05-15 WO PCT/US1998/009974 patent/WO1998051285A2/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO1998051285A3 (en) | 1999-02-25 |
| WO1998051285A2 (en) | 1998-11-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU7490098A (en) | Cationic amphiphile formulations | |
| AU1617399A (en) | Glp-1 formulations | |
| AU6513298A (en) | Therapeutic compositions | |
| AU9187598A (en) | Oral preparation | |
| AU9182498A (en) | Taste masked formulations | |
| GB9715751D0 (en) | Formulations | |
| GB9713149D0 (en) | Pharmaceutical formulations | |
| AU6805498A (en) | Toothbrush | |
| AU6740298A (en) | Pharmaceutical composition | |
| AU9067698A (en) | Toothbrush | |
| AU7426798A (en) | Toothbrush | |
| AU7964398A (en) | Dental formulation | |
| AU1827799A (en) | Oral delivery formulation | |
| AU8107998A (en) | Pharmaceutical compositions | |
| AU5778998A (en) | Toothbrush | |
| AUPO536797A0 (en) | Protected aminosugars | |
| AU7918398A (en) | Oligonucleotide derivatives | |
| AUPO521297A0 (en) | Brush | |
| AU9343098A (en) | Pharmaceutical composition | |
| AU2234397A (en) | Toothbrush | |
| AU7066098A (en) | Perfumes comprising 3-alkylcycloalkanols | |
| AU9066698A (en) | Pulverizer | |
| AU4132297A (en) | Toothbrush | |
| AU1042899A (en) | Castor | |
| AU6984998A (en) | Implement |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |